Karl Pechmann
Follow
Get notifications in MyBN when activity occurs.
Karl Pechmann
Chief Financial Officer, Company Secretary / OncoSil Medical
Karl Pechmann is a Chartered Accountant and Chartered Secretary with over 15 years of experience.
Prior to becoming chief financial officer and company secretary of OncoSil in March 2020, Mr Pechmann was the chief financial officer and company secretary of ASX-listed regulatory technology company Kyckr for almost 4 years. He was also the finance director of ASX-listed biotech company Immutep and held senior finance roles at ASX-listed and multinational organisations.
Prior to becoming chief financial officer and company secretary of OncoSil in March 2020, Mr Pechmann was the chief financial officer and company secretary of ASX-listed regulatory technology company Kyckr for almost 4 years. He was also the finance director of ASX-listed biotech company Immutep and held senior finance roles at ASX-listed and multinational organisations.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1074th | OncoSil Medical | -15% | -37% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | OncoSil Medical | $1.1m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Chief Financial Officer, Company Secretary, OncoSil Medical | 03 Nov 2020 |
